These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3522159)

  • 1. Piretanide in the treatment of essential hypertension. A double-blind comparison versus placebo.
    Verho M; Rangoonwala B; Beloso M; Maass L; Bender R; Garduno D
    Drugs Exp Clin Res; 1986; 12(5):385-91. PubMed ID: 3522159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of piretanide, a potassium stable diuretic, on serum electrolytes in patients with congestive heart failure.
    Verho M; Bückert C; Freude J; Jaeger S; Pahnke K
    Pharmatherapeutica; 1985; 4(5):288-95. PubMed ID: 3906674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of piretanide capsules on blood pressure during ergometric and isometric work loads in patients with mild to moderate essential hypertension.
    Meywald W; Maass L; Verho M; Rangoonwala B
    Pharmatherapeutica; 1985; 4(6):356-66. PubMed ID: 4080753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension.
    Verho M; Rangoonwala B; Dols W; Fratzer U; Kaczynski J; Mühlhäusler W
    Eur J Clin Pharmacol; 1984; 27(4):407-14. PubMed ID: 6394349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of penbutolol and a combination of a low dose of penbutolol with piretanide in the treatment of mild to moderate hypertension.
    Graml E; Verho M; Rangoonwala B; Englert R; Häringer E; Pahnke K
    Pharmatherapeutica; 1985; 4(4):236-43. PubMed ID: 3903788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of a low fixed-dose combination of penbutolol with piretanide in the treatment of mild to moderate hypertension: a double-blind study against placebo.
    Yasky J; Verho M; Rangoonwala B
    Pharmatherapeutica; 1986; 4(9):607-16. PubMed ID: 3763655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of penbutolol + piretanide combinations in the treatment of arterial hypertension.
    Verho M; Rangoonwala B; Pahnke K; Freude J; Häringer E
    Drugs Exp Clin Res; 1985; 11(10):717-23. PubMed ID: 3915460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piretanide, a potassium stable diuretic, in the treatment of essential hypertension: a double-blind comparison of two formulations.
    Dols W; Verho M; Rangoonwala B; Jaeger S
    J Int Med Res; 1985; 13(1):31-9. PubMed ID: 3884409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum trace-element levels in piretanide-treated hypertensives: a double-blind trial against hydrochlorothiazide plus amiloride.
    Verho M; Bossaller W; Heinen B
    Int J Clin Pharmacol Res; 1987; 7(1):5-11. PubMed ID: 3294616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of piretanide on catecholamine metabolism, plasma renin activity and serum aldosterone: a double-blind pilot comparison against hydrochlorothiazide in patients with essential hypertension.
    Verho M; Kirsten R; Bückert C
    Pharmatherapeutica; 1984; 3(9):595-606. PubMed ID: 6374680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multicenter dose-response study of the effect of indapamide in the treatment of patients with mild to moderate hypertension.
    Capone P; Vukovich RA; Neiss ES; Bolton S; Reeves RL
    Clin Ther; 1983; 5(3):305-16. PubMed ID: 6342786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum selenium levels in diuretic-treated hypertensives: a double-blind trial of piretanide against hydrochlorothiazide plus amiloride.
    Verho M; Bossaller W; Malerczyk V
    Int J Clin Pharmacol Res; 1988; 8(1):5-8. PubMed ID: 3284831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ; Leibowitz MT; Weinstein SP; Rowe ED; Mendel CM; Levy B; McMahon FG; Mullican WS; Toth PD; Cutler NR
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind multicentre study of piretanide and hydrochlorothiazide in patients with essential hypertension.
    Buckert C; Muhlhausler W; Fratzer U; Verho M
    J Int Med Res; 1984; 12(2):81-6. PubMed ID: 6373442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propranolol-hydralazine combination in essential hypertension.
    Stevens JD; Binstok G; Mullane JF; Woods JW; Pittman AW; del Greco F; Huang C; Morledge JH
    Clin Ther; 1983; 5(5):525-39. PubMed ID: 6352036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind randomized evaluation of converting enzyme inhibition as the first-step treatment of mild to moderate hypertension.
    Sassano P; Chatellier G; Amiot AM; Alhenc-Gelas F; Corvol P; Ménard J
    J Hypertens Suppl; 1984 Dec; 2(2):S75-80. PubMed ID: 6100880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.